AKT Kinase Inhibitor free base
AKT Kinase Inhibitor is an Akt kinase inhibitor.
For research use only. Not for human or veterinary use.
AKT Kinase Inhibitor structure
CAS No.: 842148-40-7
Pack sizes & pricing
Description
AKT Kinase Inhibitor is an Akt kinase inhibitor with anti-tumor activity[1].
Biological activity
In Vitro The effect of selective inhibition of Akt in proliferating cells expressing Trop-2 is studied. Akt inhibition, either by silencing or with specific drugs, induces a marked decrease in cell proliferation in cells expressing Trop-2, in a dose-dependent fashion. In Vivo Trop-2 expressing tumors subcutaneously injected in animal models show a striking reduction of growth following treatment with specific drugs that inhibit Akt activity. Therefore Akt has a central functional role in mediating the Trop-2-dependent growth stimulus.
Identifiers
- SMILES
-
CCN1C2=C(C(=NC=C2OCCCN)C#CCO)N=C1C3=NON=C3N - InChIKey
-
LWLOLQIXHMFYND-UHFFFAOYSA-N
Specifications
- MW (average)
- 357.3672
- Formula
- C16H19N7O3
- CAS No.
- 842148-40-7
- Physical state
- Solid
- Color
- White to light yellow
- Shipping
- Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
- Storage
- Powder -20℃, 3 years; 4℃, 2 years; In solvent -20℃, 1 year;
Solubility
soluble in DMSO
- In vitro
- DMSO : 20 mg/mL
Documents
References
Same target
Search Akt- BP-01938 Clifutinib free base · >98%
- BP-02089 Afatinib free base · >99%
- BP-02089A Afatinib dimaleate other · >99%
- BP-02220 BAY1125976 free base · >98%
- BP-02268A Vevorisertib trihydrochloride salt · >98%
- BP-02332 Afuresertib free base · >98%
- BP-02337 Lonafarnib free base · >98%
- BP-02343 Ipatasertib free base · >98%
Same research area
Search Cancer- BP-00006 SLF Exclusive free base · >98%
- BP-00008 NSC-339004 free base · >98%
- BP-00019 SLF-amido-C2-COOH free base · >98%
- BP-00020 PT262 free base · >98%
- BP-00022 Inolitazone free base · >98%
- BP-00024 KX2-361 free base · >98%
- BP-00030 EML4-ALK kinase inhibitor 1 free base · >98%
- BP-00037 SB 328437 free base · >98%